ConforMIS Inc (CFMS) Misses Q3 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Conformis Reports Third Quarter 2019 Financial Results
October 30, 2019 4:05 PM EDTBILLERICA, Mass., Oct. 30, 2019 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell patient-specific joint replacement implants designed to fit each patient's unique anatomy, announced today financial results for the third quarter ended September 30, 2019.
Third Quarter 2019 Summary
Total revenue of $17.3 million, a decrease of 40% year-over-year on a reported and constant currency basis, including a royalty settlement of $10.5 million in the third quarter of 2018.Product revenue of $17.1 million, a... More